Panel voted 18-4 with one abstention to recommend approval of Arena’s lorcaserin, concluding its benefits “outweigh the potential risks when used long term” in overweight and obese people
Continue reading here:
Panel advises FDA to approve lorcaserin obesity pill
If you enjoyed this post, make sure you subscribe to my RSS feed!